Dr. Lacy’s role on the biomedical company’s board includes advising Biomerica on the commercialization of Biomerica InFoods Technology platform products such as its irritable bowel syndrome product, according to a Jan. 10 news release.
Dr. Lacy has written more than 225 peer-reviewed articles and was the former co-editor-in-chief of the American Journal of Gastroenterology.
